Mark J. Gergen, Executive Chairman at Poseida Therapeutics, Inc. (PSTX), sold 30,000 shares at $9.27 ($278K) on 2024-11-26, disclosed to the SEC on 2024-11-27.
Scheduled sale ($278k) by Executive Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AMLN | SELL | 2012-03-02 | $32K | — | Filing → |
| AMLN | SELL | 2012-02-24 | $128K | — | Filing → |
| AMLN | SELL | 2007-11-02 | $22K | — | Filing → |